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Abstract
Background: Cardiac remodelling after AMI is characterized by molecular and cellular mechanisms involving both the
ischemic and non-ischemic myocardium. The extent of right ventricular (RV) dilatation and dysfunction and its relation to
pulmonary hypertension (PH) following AMI are unknown. The aim of the current study was to evaluate changes in
dimensions and function of the RV following acute myocardial infarction (AMI) involving the left ventricle (LV).
Methods: We assessed changes in RV dimensions and function 1 week following experimental AMI involving the LV free
wall in 10 mice and assessed for LV and RV dimensions and function and for the presence and degree of PH.
Results: RV fractional area change and tricuspidal annular plane systolic excursion significantly declined by 33% (P = 0.021)
and 28% (P= 0.001) respectively. Right ventricular systolic pressure measured invasively in the mouse was within the normal
values and unchanged following AMI.
Conclusion: AMI involving the LV and sparing the RV induces a significant acute decline in RV systolic function in the
absence of pulmonary hypertension in the mouse indicating that RV dysfunction developed independent of changes in RV
afterload.
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Introduction
Acute myocardial infarction (AMI) is associated with compen-
satory mechanisms involving both the left and right ventricles. In
experimental models of AMI, right ventricular (RV) hypertrophy
occurs even if the RV is initially spared [1]. Hypertrophy and
apoptosis of cardiomyocytes both at the site of AMI and at remote
unaffected sites of both the LV and the RV are seen in
biventricular remodeling following AMI [1–5]. In patients with
LV systolic dysfunction and heart failure the presence of signs
and/or symptoms of RV failure identify a subgroup of patients
with a very poor prognosis [6–10]. The mechanisms leading to RV
remodelling and dysfunction following AMI involving the LV are
not completely clear, but it is frequently assumed that LV failure
causes pulmonary hypertension (PH) and increased RV afterload
leading to RV remodelling and dysfunction. In addition, infarction
or ischemia of the RV and/or the septum are common in patients
with AMI and can also contribute to abnormal RV systolic
function. However studies concerning RV remodelling are few
and the extent, time and causes for RV dilatation and dysfunction
remain unclear [11]. In the current study we evaluated the
occurrence and extent of RV dilatation and dysfunction in a
mouse model of AMI in which the septum and RV are spared thus
eliminating the possibility that RV or septal ischemia/infarction
leads to abnormal RV perfusion or mechanics, and in which the
RV systolic pressure could be invasively measured. We hypoth-
esized that increased RV afterload due to PH leads to impaired
RV function following AMI.
Methods
Experimental AMI
Adult male out-bred ICR mice were purchased from Harlan
Laboratories (Indianapolis, IN). All animal experiments were
conducted under the guidelines on humane use and care of
laboratory animals for biomedical research published by the US
National Institutes of Health (NIH Publication No. 85–23, revised
1996). The study protocol was approved by the local Institutional
Animal Care and Use Committee. Mice underwent experimental
myocardial infarction due to permanent coronary artery ligation
or sham surgery as previously described [12]. All mice underwent
transthoracic echocardiography before surgery and at 2 and 7 days
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and a subgroup of mice also 10 weeks after surgery. Doppler
echocardiography was performed with the Vevo770 imaging
system (VisualSonics Inc, Toronto, Canada) as previously
described and measurements were performed according to the
to the American Society of Echocardiography recommendations
[13]. The left ventricular (LV) end-diastolic diameter (LVEDD),
LV end-systolic diameters (LVESD) were measured at M-mode.
LV fractional shortening (LVFS) was calculated. The LV and
right ventricle (RV) diastolic and systolic areas were traced in the
parasternal short axis mid-ventricular view (Figure 1). The LV
and RV fractional area change velocity (LVFAC and RVFAC,
respectively), a load- and rate-independent indexes of contractil-
ity, were computed dividing the fractional area changes by the
rate-corrected ejection time. The tricuspidal annular plane
systolic excursion was also measured to quantify right ventricular
function. To evaluate for interventricular dyssynchrony, we
measured the electromechanical delay using (a) Doppler analysis
of the pulmonary artery (for the RV) and of the aorta (for the LV)
measuring the time between the start of the QRS on the
electrocardiogram and the start of the forward flow, and (b) using
the M-mode echocardiography of the mitral annulus plane and
tricuspidal annulus plane systolic excursion and measuring the
time between the start of the QRS on the electrocardiogram and
the start of the inward motion of the lateral portion of the
annulus. The differences between the LV and RV delays were
used as measures of dyssynchrony. The investigator performing
and reading the echocardiogram was blinded to the group
allocation.
In an additional group of mice (ligation or sham [N=5] per
group) were deeply sedated and intubated 7 days after surgery, the
chest was reopened, the RV or LV apex were punctured and a
Millar catheter connected to a pressure transducer to measure RV
peak systolic pressure, which is equivalent to pulmonary artery
systolic pressure in the absence of pulmonary valve stenosis, or LV
end-diastolic pressure. An additional group of mice (ligation or
sham [N=5] per group) underwent measurement of RV peak
systolic pressure or LV end-systolic pressure after challenge with
0.4 ml of NaCl 0.9% or isoproterenol 10 ng (Sigma Aldrich, St.
Louis, MO, US) to evaluate for latent PH.
The extent of the infarct was evaluated using two different
methods. Triphenyl tetrazolium chloride (TTC) was used to stain
viable myocardium samples at 24 hours and Masson’s trichrome
histochemical staining for the measurement of infarct size as
reparative fibrosis (scar), as previously described [14] (Figure 1).
The presence of pulmonary edema was assessed by measuring
lung water content 7 days after AMI: the lungs were dissected,
weighed, dried at 60uC (24 hrs), and then re-weighed to calculate
wet-to-dry ratio.
As an additional AMI model, we added a group of mice (N=6),
which underwent transient coronary artery ligation (30 min)
followed by reperfusion in order to simulate a reperfused AMI,
often seen in patients, which is also characterized by a smaller
degree of LV injury. The surgical technique is as described above
with the difference that the ligation was released 30 min later.
These mice underwent echocardiography prior to surgery and 7
days later.
Statistical analysis
The values are reported as mean and standard error. ANOVA
for repeated measure analysing the effect of time, group and time x
group interaction was used to compare variables between the
animal groups. The analyses were completed using SPSS 16.0
software (Chicago, IL).
Results
Experimental AMI
Surgical ligation of the left coronary artery was associated with a
significant reduction in LVFS, LVEF and LV fractional area
change at 48 hours, 7 days and 10 weeks after surgery and a
significant increase in LV dimensions (LVEDD, LVESD, LV
diastolic area and LV systolic area) by day 7. At day 7, LV
fractional area change velocity (a load- and rate-independent
index of contractility) decreased by 45% (P,0.001). Cardiac
output estimated by Doppler did not significantly change reflecting
a condition of compensated LV dysfunction (Table 1).
RV fractional area change was significantly reduced at 48 hours
(221%, P=0.049), 7 days (239%, P= 0.002), and 10 weeks
(228%, P=0.004), while RV diastolic area significantly increased
by day 7 (+20%, P,0.001)(Figure 1, Table 1). At day 7, RV
fractional area change velocity decreased by 28%
(P= 0.042)(Figure 1, Table 1). TAPSE was also significantly
reduced at day 7 (227%, P,0.001, Figure 1, Table 1), however
the changes in tricuspidal annulus systolic velocity at tissue
Doppler did not reach statistical significance.
There was no evidence of interventricular dyssynchrony 7 days
after surgery: the Doppler measured delay difference between aorta
(LV) and pulmonary artery (RV) was 2.660.3 ms in the AMI group
and 2.360.4 ms in the sham-operated mice (P= 0.67), theM-Mode
measured delay difference between the mitral annulus plane (LV)
and the tricuspidal annulus plan (RV) was 060.6 in the AMI group
and 1.661.0 ms in the sham-operated mice (P= 0.27).
>Invasively measured RV systolic pressure and LV end-diastolic
pressure were virtually unchanged after AMI (2061 mmHg [sham]
vs 2062 [AMI], P=0.92; and 361 mmHg [sham] vs 461 [AMI],
P=0.76; respectively), and unchanged after NaCl 0.9% or
isoproterenol challenge (data not shown). The lung water content
was not increased after AMI reflecting absence of pulmonary edema
(7860.8% vs 77.860.8% in the sham operated mouse, P=0.22).
The extent of infarct size was similar using both TTC (2963%)
and Masson’s trichrome (28%63%), and in all cases the infarct
involved only the anterior and lateral wall while the RV and
septum were not involved.
Mice with reperfused AMI showed a significantly smaller infarct
size using both TTC (1462%, P,0.001 vs non-reperfused) and
Masson’s trichrome (1363%, P,0.001 vs non-reperfused) and a
smaller decrease in LVFAC (3864%, P,0.001 vs non-reperfused)
yet a similar reduction in RVFAC (3065%, P= 0.48, Figure 1).
The changes in RVFAC were not statistically correlated with
the size of infarct or the changes in LVFAC in the non-reperfused
AMI group, in the reperfused AMI group, or in the 2 groups
combined (data not shown), whereas LVFAC correlated signifi-
cantly with infarct size in the 2 groups combined (R=20.86,
P,0.01) but not in the individual groups. RVFAC and LVFAC as
absolute values were highly correlated in the 2 groups combined
(R=+0.97, P,0.01) but not in the individual groups.
Discussion
Post-infarction cardiac remodelling is characterized by biven-
tricular remodelling. The occurrence of RV dysfunction and
failure identifies a subgroup of patients with extremely poor
prognosis, however only few clinical studies have systematically
addressed RV remodelling following AMI [7–9,15]. Potential
mechanisms include ischemia/infarct of the RV, septal dyssyner-
gy, pulmonary hypertension, neurohormonal activation or inflam-
mation [11,16]. Our data shows that a significant degree of RV
systolic dysfunction ensues acutely after AMI in the absence of RV
RV Dysfunction in AMI in Absence of Pulmonary HTN
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Figure 1. Right ventricular remodeling in AMI. Panel A shows cross-section of the left and right ventricles (apical section) stained with Masson’s
trichrome to identify fibrous scar in the infarct. Involvement of a large area of the anterolateral left ventricle free wall (arrows) and sparing of the
interventricular septum and right ventricle (*) is evident. Panel B shows an echocardiographic image (short axis view) of the left and right ventricles
(mid-ventricular section) in a mouse 7 days after permanent coronary artery ligation. An aneurysm of the anterolateral left ventricular free wall is
noted (arrows). The interventricular septum is indicated by (*) and the right ventricular cavity is indicated by (N). Panel C shows a M-mode recording
on the tricuspidal annulus plane systolic excursion (TAPSE) obtained from a 4-chamber apical view. Panels D and E show changes in right ventricular
fractional area change (RVFAC) and tricuspidal annulus plane systolic excursion (TAPSE) over time in mice with AMI due to permanent coronary
ligation and mice with sham operation (N= 10 per group). Panel F shows right ventricular systolic pressure (RVSP) in mice with AMI due to permanent
coronary ligation and mice with sham operation 7 days after surgery with no differences noted between the groups (N= 5 per group). Panel G shows
the lack of correlation between RVSP and RVFAC in mice with AMI due to permanent coronary ligation and mice with sham operation 7 days after
surgery. Panels H and I show data deriving from the model of reperfused AMI as it compares with the non-reperfused AMI: reperfused AMI had a
smaller decline in LV systolic function (LVFAC, panel H) yet a similar decline in RV systolic function (RVFAC, panel I).
doi:10.1371/journal.pone.0018102.g001
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ischemia/infarct or septal infarct, and in the absence of pulmonary
hypertension. These data are in accordance to data obtained in
patients with chronic heart failure in which progressive RV
enlargement occurred in the absence of PH [16–17], and call for a
refocusing on cellular and molecular events occurring in the RV
myocardium rather than in the pulmonary circulation when trying
to explain the development of RV failure [11,17]. These data seem
also to imply that the LV and RV may be working as a ‘functional
syncytium’ and that the two ventricles cannot be dissociated in an
independent manner since the architecture of the distinct
myocardial bands makes it mandatory for an integrated and
unified function of both chambers [18–19]. Seminal work in the
isolated rabbit heart (independently of pulmonary circulation and
neural, humoral and pericardial influences) had showed that
reduced LV systolic function induced by a damage to the LV free
wall inevitably led to RV systolic dysfunction [19], we confirm and
expand such findings by showing that RV systolic dysfunction
occurs in vivo in the mouse independent of changes in RV
afterload. We also report that the degree in RV dysfunction is not
linearly correlated with LV infarct size. The reasons why neither
LV end-diastolic pressure nor RV systolic pressure increase after
AMI in the mouse are not clear, yet serve well as a model to
understand RV remodelling in the absence of PH.
RV remodelling and dysfunction following AMI may therefore
simply be part of a global biventricular remodelling response due
to altered wall stress which is further aggravated by neurohor-
monal activation during and after AMI [16–17,20]. LV and RV
failure may be independently or concomitantly contributing to
heart failure, as reflected by the fact that LV systolic function and
RV systolic function are closely correlated. RV trabeculae from
rats with AMI involving the LV showed impaired calcium
handling and contractility independent of ischemia and prevented
by angiotensin receptor blockade [20]. Similarly, improvements in
LV and RV systolic function occur with carvedilol in patients with
chronic systolic heart failure [16]. In the SAVE and VALIANT
studies enrolling patients with recent AMI and LV systolic
dysfunction, each 5% decrease in RV fractional area change (a
surrogate for RV ejection fraction) was associated with a 16–30%
increased odds of cardiovascular mortality [6,10].
In conclusion, acute myocardial infarction involving the LV and
sparing the septum and the RV induces a significant acute decline
in RV systolic function in the absence of pulmonary hypertension
in the mouse. RV systolic dysfunction following AMI may
represent an additional mechanism by which AMI may cause
heart failure and increased mortality. These finding remain to be
validated and to be mechanistically investigated, ultimately leading
to clinical studies addressed at determining whether RV systolic
function is an independent and modifiable predictor of mortality.
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